TLDR:
- ZAKA VC launches its first €15M fund to support early-stage startups in CEE and beyond.
- Fund I is aimed at B2B software, AI, biotech, and health tech startups.
Czech-founded ZAKA VC has announced the establishment of its first fund, sized at €15M. Fund I is launching with a €10.5M first closing in June of this year. The fund is aimed at supporting early-stage startups across the US and EU markets.
ZAKA VC, founded in 2020 by Jan Kasper and Peter Zalesak, initially invested private money into pre-seed and seed startups in the CEE market. The demand from external investors led to the creation of the first venture capital fund, which aims to invest in pre-seed and seed-stage startups across Europe and the US, with a focus on B2B software, AI, biotech, and health tech.
Entrepreneurs Jan Kasper and Peter Zalesak have built and co-own over 60 companies with a turnover exceeding €1.4B in various sectors. Their motivation to create ZAKA VC was driven by the emerging startup ecosystem, aiming to invest in startups and help them scale. ZAKA VC’s first fund is a step towards supporting innovation and entrepreneurship in Europe and beyond.
